HomeCompareMGRM vs NNN

MGRM vs NNN: Dividend Comparison 2026

MGRM yields 33.33% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGRM wins by $134.6K in total portfolio value
10 years
MGRM
MGRM
● Live price
33.33%
Share price
$6.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$160.1K
Annual income
$23,203.52
Full MGRM calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — MGRM vs NNN

📍 MGRM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGRMNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGRM + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MGRM pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGRM
Annual income on $10K today (after 15% tax)
$2,833.33/yr
After 10yr DRIP, annual income (after tax)
$19,722.99/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, MGRM beats the other by $17,481.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGRM + NNN for your $10,000?

MGRM: 50%NNN: 50%
100% NNN50/50100% MGRM
Portfolio after 10yr
$92.8K
Annual income
$12,920.47/yr
Blended yield
13.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

MGRM
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$5.40
-10.0% upside vs current
Range: $5.40 — $5.40
Altman Z
12.6
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGRM buys
0
NNN buys
0
No recent congressional trades found for MGRM or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGRMNNN
Forward yield33.33%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$160.1K$25.6K
Annual income after 10y$23,203.52$2,637.42
Total dividends collected$113.6K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$5.40$44.93

Year-by-year: MGRM vs NNN ($10,000, DRIP)

YearMGRM PortfolioMGRM Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$14,033$3,333.33$10,737$617.02+$3.3KMGRM
2$19,387$4,371.75$11,577$710.93+$7.8KMGRM
3$26,389$5,644.57$12,538$822.59+$13.9KMGRM
4$35,417$7,180.46$13,645$956.06+$21.8KMGRM
5$46,902$9,006.44$14,925$1,116.51+$32.0KMGRM
6$61,333$11,146.93$16,415$1,310.57+$44.9KMGRM
7$79,249$13,622.82$18,158$1,546.77+$61.1KMGRM
8$101,247$16,450.69$20,213$1,836.20+$81.0KMGRM
9$127,976$19,642.17$22,649$2,193.37+$105.3KMGRM
10$160,138$23,203.52$25,558$2,637.42+$134.6KMGRM

MGRM vs NNN: Complete Analysis 2026

MGRMStock

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Full MGRM Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this MGRM vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGRM vs SCHDMGRM vs JEPIMGRM vs OMGRM vs KOMGRM vs MAINMGRM vs ADCMGRM vs EPRTMGRM vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.